Pyxis Oncology rakes in $22 mln Series A

Boston-based Pyxis Oncology, a newly formed immuno-oncology company, has raised $22 million in Series A funding. Leaps by Bayer led the round with participation from other investors that included Agent Capital, Ipsen and Longwood Fund.

Source: Press Release